Live cell integrated surface plasmon resonance biosensing approach to mimic the regulation of angiogenic switch upon anti-cancer drug exposure.
about
Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.In situ targeting TEM8 via immune response and polypeptide recognition by wavelength-modulated surface plasmon resonance biosensor.Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.
P2860
Live cell integrated surface plasmon resonance biosensing approach to mimic the regulation of angiogenic switch upon anti-cancer drug exposure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@ast
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@en
type
label
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@ast
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@en
prefLabel
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@ast
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@en
P2093
P2860
P50
P356
P1433
P1476
Live cell integrated surface p ...... pon anti-cancer drug exposure.
@en
P2093
Chen-Zhong Li
Hongyun Liu
Jun-Jie Zhu
P2860
P304
P356
10.1021/AC402659J
P407
P577
2014-07-15T00:00:00Z